Ignite Creation Date:
2024-05-05 @ 4:45 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00306215
Status:
COMPLETED
Last Update Posted:
2023-08-25
First Post:
2006-03-21
Brief Title:
A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohns Disease
Sponsor:
ChemoCentryx
Organization:
ChemoCentryx
Study Overview
Official Title:
A Multinational Double-blind Placebo-controlled Parallel Group Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohns Disease
Status:
COMPLETED
Status Verified Date:
2023-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether CCX282-B is effective in treating patients with moderate to severe Crohns Disease
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None